Exelixis EXEL Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's operating lease liabilities?
- Exelixis (EXEL) reported operating lease liabilities of $169.54M in Q1 2026.
- How has Exelixis's operating lease liabilities changed year-over-year?
- Exelixis's operating lease liabilities decreased by 9.4% year-over-year, from $187.13M to $169.54M.
- What is the long-term trend for Exelixis's operating lease liabilities?
- Over 5 years (2020 to 2025), Exelixis's operating lease liabilities has grown at a 28.7% compound annual growth rate (CAGR), from $49.09M to $173.04M.
- What does operating lease liabilities mean?
- The portion of long-term lease payments for facilities and equipment due after one year.
- How do you interpret operating lease liabilities?
- Increases reflect expansion of physical footprint or long-term facility commitments, while decreases indicate the natural amortization of lease terms.
- How does operating lease liabilities compare across companies?
- Common for all companies; biopharma firms with significant lab and manufacturing footprints will have higher values here.